Medicinova, Inc.

MNOVNASDAQ • USD
1.43 USD
↗ 0.04 (2.81%)🟢LIVE (AS OF 12:58 PM EDT)
🟢Market: OPEN

Medicinova, Inc. (MNOV) is currently trading at $1.43. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. MNOV is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 23, 2026.

Open?$1.42
High?$1.47
Low?$1.39
Prev. Close?$1.39
Volume?62.6K
Avg. Volume?646.5K
VWAP?$1.44
Rel. Volume?0.10x
Bid / Ask
Bid?$1.40 × 100
Ask?$1.42 × 100
Spread?$0.02
Midpoint?$1.41
Valuation & Ratios
Market Cap?68.4M
Shares Out?49.2M
Float?40.3M
Float %?81.9%
P/E Ratio?N/A
P/B Ratio?1.84
EPS?-$0.22
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
Employees
6
Market Cap
68.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2006-12-07
Address
4275 EXECUTIVE SQUARE
LA JOLLA, CA 92037
Phone: 858-373-1500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
94
Short Sent.?
95
Piotroski F-Score?3/9Weak
Altman Z-Score?-2.65Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.84%Low
Short Interest?339.1K
Days to Cover?1.0
Free Float40.3M
Avg Daily Volume1.6M
Settlement Date2026-09-30
Financial Health
Current Ratio?8.75Strong
Quick Ratio?8.75Strong
Cash Ratio?8.58Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
79
1.84CHEAP▾
P/S?
Peers
100
S&P
3
74.33HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
46.72HIGH▾
Returns & Efficiency
ROE?
S&P
6
-28.8%WEAK▾
ROA?
S&P
3
-26.6%WEAK▾
Cash Flow & Enterprise
FCF?$-9123980
Enterprise Value?$43.0M
Fundamentals ratios updated end of day